Well of Art Investor Deck II
Well of Art · Investor presentation · October 2026

Glaze — a structured creative process, built to be proven in care.

We are building Well of Art as a healthcare company.
Our product is Glaze, a painting platform for iPad and Apple Pencil.
Our objective is independent scientific evidence that a structured
painting process measurably helps children, older adults and patients.

Well of ArtGlaze
The problem

Arts in care work where someone
runs them. Most places have no one.

Patients lose agency

Hospital stays, long-term treatment and residential care take control away from the person. Anxiety and passivity follow.

Arts programs depend on people

Hospital art programs, art therapists and museum educators are effective but scarce. They do not reach most wards, most hospitals or most care homes.

Funding follows evidence

Foundations and hospitals both fund programs that can show measured outcomes. Arts-in-health lacks interventions standardised enough to be studied and repeated at scale.

Glaze is designed to work where no program exists — self-operating, the same at every bedside, and structured so that its effect can be measured.

Glaze on iPad: a still-life being painted with the brush and Wet/Dry controls
The product

Glaze: a digital twin of historical
oil glazing, delivered as a guided process.

Real paint behaviour

Brush and pigment parameters come from laboratory research on the optics of historical pigments and glazes (Bialystok University of Technology, EU-funded, 2020–2022). Proprietary IP.

Structured, not open-ended

Each artwork comes with a curatorial description, an interactive sketch or step-by-step tutorial. A blank canvas is always an option. The patient decides.

Self-operating

About two minutes to learn the full app. No staff presence required. No ads, no in-app purchases, no account.

No patient data

Paintings are saved to the patient's own device via QR code. Nothing about the patient is collected — this is what allowed entry into a hospital IT environment.

Dedicated versions are built per institution from its own collection, or from the Well of Art museum library: 220+ works from 15+ collections (including the National Museum
in Kraków, the Royal Castle in Warsaw – Museum, the Metropolitan Museum of Art, the National Gallery of Art in Washington and the J. Paul Getty Museum).

Traction

A mature product, already in real use.

15,000+

individual users of the public version

400

iPads running Glaze at Stanford Medicine Children's Health

8

partner museums

10+

institutions in discussion

Recognition

GP Bullhound Allstars

Award · 2023

ArtTech Prize

Finalist · 2023

Paszporty Polityki

Distinction · 2023

Orły Innowacji

Finalist · 2024

How we got here

Six years from paint research to a hospital deployment.

2020 – 2022

Research on paint

EU-funded lab study of how historical pigments and translucent layers behave. The findings set the architecture of Glaze.

Museums & schools

Observation in context

A dozen-plus museum projects, 8 partner museums and school deployments. The same process observed across ages and settings.

Iteration

Dozens of app versions

Each version tested with users and revised. 15,000+ individual users now feed back into the product.

2025

First publication

Glaze in a mandatory surgical-education curriculum at King Abdulaziz University. Peer-reviewed, Journal of Surgical Education.

2026

Stanford & Boston

Dedicated version on 400 iPads at Stanford Medicine Children's Health after a two-year institutional review. Joint presentation at the Bridging Visual Arts & Healthcare symposium (Brigham and Women's / Harvard Medical School).

Each stage was a precondition for the next. The product is now mature and deployed. What is missing is independent evidence of effect — and that is what this round funds.

What we observed — and what we will test

A consistent observation, turned into a testable chain.

Across museums, schools and hospitals we repeatedly saw sustained attention and
engagement, regardless of age or artistic experience. Observation is not evidence.
So we formulated it as a hypothesis with links that can each fail.

A hypothesis under development, not a finding. Research framework and constructs (agency, flow, anxiety, positive affect) follow the research packet prepared by Knology.

The evidence plan

From feasibility to a published result —
independent by design.

Done

Foundation

  • Laboratory R&D on paint opticsBialystok University of Technology, 2020–22
  • Peer-reviewed publicationKAU Jeddah, J. Surgical Education, 2025
  • Hospital-grade deploymentStanford Medicine Children's Health, 2026
  • Research frameworkdeveloped with Knology
H1 2027

Feasibility

  • Pediatric hospitalthe primary setting
  • School or librarya second setting to validate the measures; faster ethics review and recruitment
  • Purposeconfirm that the measures work and participants can be recruited — the basis for the main study
H2 2027 – end of 2028

Main study

  • Outcomesstress and anxiety, sense of agency
  • ComparisonGlaze against a standard activity
  • Resultsubmitted for peer-reviewed publication

Study design is being agreed with our research partners. We do not evaluate our own platform: design,
data collection, analysis and publication sit with independent researchers. Credibility comes from that separation.

Research partners

The right partners decide what the evidence is worth.

Scoped

Knology

New York non-profit social-science research organisation with long experience in human-subjects research in museums, libraries and institutions serving children. Stage 1 proposal received: literature review, instruments, pretesting, feasibility study, conference poster.

Defining scope

Performance Hypothesis

Atlanta-based research and evaluation firm specialising in arts and health. Founded by specialists in healthcare evaluation and statistics, it designs and measures creative wellbeing programs for hospitals, universities, arts organisations and foundations.

In discussion

Hospitals

Stanford Medicine Children's Health is the natural feasibility candidate. Further conversations with US and European pediatric institutions.

Our structural advantage

Evidence is not a gate to sales. It is the multiplier.

Today — without proof

After — with proof

Glaze is not a medical device and does not need clearance to be used. Foundations and institutions can fund it now as an arts and engagement program.

Payers want independent evidence. It changes how much they commit and how far we reach.

Sales cycle startedConversations are under way. Institutional cycles are long — Stanford took two years — so we plan for first revenue from them in H2 2028.
FundingLarger and multi-year commitments from foundations and hospitals, in parallel.
Data during researchEvery deployment is a potential study site and a source of in-app metrics.
ChannelApple. Glaze runs only on iPad and Apple Pencil. We are in early conversations with Apple's healthcare and education teams, who expect research before going further.
Two payersFoundations fund dedicated versions; hospitals and museums also pay directly.
ReachHospitals without an arts program can adopt Glaze on the strength of published results, not only through a local champion.
Where it scales

One validated process, six institutional settings.

SettingWho it serves

Pediatric hospitals

Children in long-term or repeated treatment

Senior care homes

Older adults; loneliness, cognitive engagement

Child mental-health clinics

Private outpatient support for children

Museums

Visitors and education programs; collections as content

Schools

Students; public version free

Libraries

Community programs

The product is the same in each setting; only the dedicated collection and educational content change. Museums act as both a content source and a bridge to hospitals.

Business model

Two payers. One community of champions.

$20k

per institution per year — Founding Partner price, limited to 20 per category worldwide

$40k

per institution per year after the Founding cohort

Two payers, in parallel

Foundations fund dedicated versions for hospitals and museums; one foundation can support several institutions. Hospitals and museums also pay directly. Schools and individuals use the public version free.

Champions

Curators, art therapists and arts program leads bring Glaze into their institutions and ask their sponsors to fund it. We build this network through conferences and professional relationships, not cold outreach.

The ask
$2.46M

Investment

20%

Equity

Through the end of 2028: reach independent evidence of effect,
build relationships with the arts-in-health community,
and put Glaze into its next healthcare institutions.

Evidence

Feasibility study, then the main study, with independent research partners. Clinical site, ethics approval, measures, in-app metrics.

Arts-in-health community

Presence where arts-in-health practitioners meet: conferences, professional networks, an advisory circle, a US hospital partnerships lead.

Development

Improving the Glaze product engine, building out further elements of the app, and developing AI capabilities.

H1 2027

Clinical site and ethics approval confirmed; feasibility study in a hospital and a second setting.

H2 2027

Feasibility results; main study begins.

2028

Main study running; first paying institutions beyond Stanford.

End of 2028

Results submitted for publication; ready for distribution partners.

Key people

Painting, engineering, education, institutions.

Robert Latoś

Founder & CEO · painter · product concept and hospital program

Marcin Molski

Co-founder · team management and production

Bartosz Maciurak

Painting engine and core engineering

Zofia Czartoryska

Curatorial content and cultural partnerships

Julia Konieczna

Art educator · educational concept

rlatos@wellofart.com · wellofart.com

Well of ArtGlaze
The team behind Glaze

Since 2019, 51 people have worked on Glaze.

22
Development

Janusz Bossy · Maksymilian Kotłowski · Mateusz Gawenda · Michał Wolecki · Tomasz Parzych · Jarosław Szczerbaty · Anna Dąbrowska · Arkadiusz Bienert · Błażej Brojek · Maciej Zębala · Mariusz Osiński · Łukasz Sosiński · Michał Sibera · Daniel Twork · Łukasz Mielnikowski · Rafał Łukaszewski · Wojtek Hatey · Michał Wołyniec · Marcin Zglinicki · Marcel Starczyk · Łukasz Kudzia · Łukasz Lech

11
Scientific research
Bialystok University of Technology

Prof. Krzysztof Molski · Prof. Sławomir Obidziński · Prof. Roman Kaczyński · Prof. Jolanta Pauk · Dr hab. Piotr Mrozek · Dr Bogusław Hościło · Dr Ewa Mrożek · Dr Piotr Tarasiuk · Dr Andrzej Werner · Eliza Romańczuk, MSc · Krzysztof Stankiewicz, MSc

7
Leadership and core team
Concept and supervisionRobert Latoś
Production managementMarcin Molski
Painting engineBartosz Maciurak
Core engineeringBartosz Maciurak · Marcin Górzyński
Educational conceptJulia Konieczna
Curatorial and art contentZofia Czartoryska
Marketing and communicationZofia Czartoryska · Jarek Wiewiórski
6
Project management

Michał Mycka · Tomas Głodkowski · Aleksander Ziarniak · Anna Łazarczyk-Łukasik · Bogumiła Kwiatkowska-Koterba · Kacper Łotowski

5
Graphic design

Rafał Staromłyński · Marcin Kowalski · Paweł Schendler · Anita Błędowska · Feliks Marciniak